The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Roach, M., Hanks, G., Thames, H., Schellhammer, P., Shipley, W. U., Sokol, G. H., & Sandler, H. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.04.029 · Cited by 2,749
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., & Redwine, E. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710083171501 · Cited by 2,451
Thompson, I. M., Pauler, D. K., Goodman, P. J., Tangen, C. M., Lucia, M. S., Parnes, H. L., Minasian, L. M., Ford, L. G., Lippman, S. M., Crawford, E. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031918 · Cited by 2,446
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Garmo, H., Stark, J. R., Busch, C., Nordling, S., Häggman, M., Andersson, S.-O., Bratell, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011967 · Cited by 1,900
Catalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Flanigan, R. C., Patel, A., Richie, J. P., deKernion, J. B., Walsh, P. C., Scardino, P. T., et al. (1998) · JAMA · doi:10.1001/jama.279.19.1542 · Cited by 1,162
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043739 · Cited by 1,111
Longitudinal Evaluation of Prostate-Specific Antigen Levels in Men With and Without Prostate Disease
Carter, H. B. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480160073037 · Cited by 1,096
Scher, H. I., & Sawyers, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4777 · Cited by 1,025
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Thompson, I. M., Ankerst, D. P., Chi, C., Goodman, P. J., Tangen, C. M., Lucia, M. S., Feng, Z., Parnes, H. L., & Coltman, C. A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj131 · Cited by 938
Stenman, U., Leinonen, J., Alfthan, H. V., et al. (1991) · PubMed · Cited by 930
Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin
Lilja, H., Christensson, A., Dahlén, U., Matikainen, M. T., Nilsson, O., Pettersson, K., & Lövgren, T. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.9.1618 · Cited by 910
Self-citationPreoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy
D'Amico, A. V., Chen, M.-H., Roehl, K. A., & Catalona, W. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032975 · Cited by 740
Lilja, H. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112185 · Cited by 734
Self-citationThompson, I. M. (2005) · JAMA · doi:10.1001/jama.294.1.66 · Cited by 704
CHRISTENSSON, A., LAURELL, C., & LILJA, H. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19466.x · Cited by 641
Self-citationStephenson, A. J., Kattan, M. W., Eastham, J. A., Dotan, Z. A., Bianco, F. J., Lilja, H., & Scardino, P. T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0756 · Cited by 529
Self-citationAge-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men
Morgan, T. O., Jacobsen, S. J., McCarthy, W. F., Jacobson, D. J., McLeod, D. G., & Moul, J. W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608013350502 · Cited by 412
AMLING, C. L., BERGSTRALH, E. J., BLUTE, M. L., SLEZAK, J. M., & ZINCKE, H. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)66452-x · Cited by 408
Lilja, H., Oldbring, J., Rannevik, G., & Laurell, C. B. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113070 · Cited by 395
Self-citationAMLING, C. L., BERGSTRALH, E. J., BLUTE, M. L., SLEZAK, J. M., & ZINCKE, H. (2001) · The Journal of Urology · doi:10.1097/00005392-200104000-00020 · Cited by 348
Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate Cancer
Thompson, I. M., Chi, C., Ankerst, D. P., Goodman, P. J., Tangen, C. M., Lippman, S. M., Lucia, M. S., Parnes, H. L., & Coltman, C. A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj307 · Cited by 323
D’Amico, A. V., Renshaw, A. A., Sussman, B., & Chen, M.-H. (2005) · JAMA · doi:10.1001/jama.294.4.440 · Cited by 323
Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
Donovan, J., Hamdy, F., Neal, D., Peters, T., Oliver, S., Brindle, L., Jewell, D., Powell, P., Gillatt, D., Dedman, D., et al. (2003) · Health Technology Assessment · doi:10.3310/hta7140 · Cited by 290
Prostate-Specific Antigen-Activated Thapsigargin Prodrug as Targeted Therapy for Prostate Cancer
Denmeade, S. R., Jakobsen, C. M., Janssen, S., Khan, S. R., Garrett, E. S., Lilja, H., Christensen, S. B., & Isaacs, J. T. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.990 · Cited by 285
Self-citationArmstrong, A. J., Garrett-Mayer, E., Ou Yang, Y.-C., Carducci, M. A., Tannock, I., de Wit, R., & Eisenberger, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.4769 · Cited by 275
Prostate-Specific Antigen Values at the Time of Prostate Cancer Diagnosis in African-American Men
Moul, J. W. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530160029029 · Cited by 271
Age and Racial Distribution of Prostatic Intraepithelial Neoplasia
Sakr, W., Grignon, D. J., Haas, G. P., Heilbrun, L. K., Pontes, J. E., & Crissmana, J. D. (1996) · European Urology · doi:10.1159/000474163 · Cited by 258
Andriole, G. L., Levin, D. L., Crawford, E. D., Gelmann, E. P., Pinsky, P. F., Chia, D., Kramer, B. S., Reding, D., Church, T. R., Grubb, R. L., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji065 · Cited by 244
Labrie, F., Candas, B., Cusan, L., Gomez, J. L., Bélanger, A., Brousseau, G., Chevrette, E., & Lévesque, J. (2004) · The Prostate · doi:10.1002/pros.20017 · Cited by 227
Lu-Yao, G., Albertsen, P. C., Stanford, J. L., Stukel, T. A., Walker-Corkery, E. S., & Barry, M. J. (2002) · BMJ · doi:10.1136/bmj.325.7367.740 · Cited by 216
Stamey, T. A., Kabalin, J. N., Ferrari, M., & Yang, N. (1989) · Journal of Urology · doi:10.1016/s0022-5347(17)41177-3 · Cited by 205
Loeb, S., Roehl, K. A., Antenor, J. A. V., Catalona, W. J., Suarez, B. K., & Nadler, R. B. (2006) · Urology · doi:10.1016/j.urology.2005.08.040 · Cited by 184
NONPROSTATIC SOURCES OF PROSTATE-SPECIFIC ANTIGEN
Diamandis, E. P., & Yu, H. (1997) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70373-6 · Cited by 172
Miller, J. I., Ahmann, F. R., Drach, G. W., Emerson, S. S., & Bottaccini, M. R. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37432-3 · Cited by 163
Proenzyme Forms of Prostate-Specific Antigen in Serum Improve the Detection of Prostate Cancer
Mikolajczyk, S. D., Catàlona, W. J., Evans, C. L., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.026823 · Cited by 156
Kupelian, P. A., Kuban, D., Thames, H. D., Levy, L., Horwitz, E. M., Martinez, A. A., Michalski, J. M., Pisansky, T. M., Sandler, H. M., Shipley, W. U., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.05.018 · Cited by 124
Telesca, D., Etzioni, R., & Gulati, R. (2007) · Biometrics · doi:10.1111/j.1541-0420.2007.00825.x · Cited by 123
Prognostic Significance of Prostate Specific Antigen in Endocrine Treatment for Prostatic Cancer
Arai, Y., Yoshiki, T., & Yoshida, O. (1990) · The Journal of Urology · doi:10.1016/s0022-5347(17)39757-4 · Cited by 122
Comparison of biochemical failure definitions for permanent prostate brachytherapy
Kuban, D. A., Levy, L. B., Potters, L., BEYER, D. C., Blasko, J. C., Moran, B. J., Ciezki, J. P., Zietman, A. L., Zeléfsky, M. J., Pisansky, T. M., et al. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.03.027 · Cited by 118
In Situ Hybridization of Prostate-Specific Antigen mRNA in Human Prostate
Qiu, S.-D., Young, C. Y. F., Bilhartz, D. L., Prescott, J. L., Farrow, G. M., He, W.-W., & Tindall, D. J. (1990) · The Journal of Urology · doi:10.1016/s0022-5347(17)39797-5 · Cited by 107
D'Amico, A. V., & Roehrborn, C. G. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70981-0 · Cited by 107
The Effectiveness of Screening for Prostate Cancer
Concato, J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.1.38 · Cited by 106
Marks, L. S., Andriole, G. L., Fitzpatrick, J. M., Schulman, C. C., & Roehrborn, C. G. (2006) · The Journal of Urology · doi:10.1016/j.juro.2006.04.024 · Cited by 89
DAVIDCRAWFORD, E., DeAntoni, E. P., Etzioni, R., Schaefer, V., OLSON, R., & Ross, C. W. (1996) · Urology · doi:10.1016/s0090-4295(96)00061-1 · Cited by 88
Zhang, W., Finne, P., Leinonen, J., Vesalainen, S., Nordling, S., Rannikko, S., & Stenman, U. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.12.2471 · Cited by 81
Coldman, A. J., Phillips, N., & Pickles, T. (2003) · Europe PMC (PubMed Central) · Cited by 81
Ryan, C. J., Smith, A., Lal, P., Satagopan, J. M., Reuter, V. E., Scardino, P. T., Gerald, W. L., & Scher, H. I. (2006) · Urology · doi:10.1016/j.urology.2006.04.016 · Cited by 72
Väisänen, V., Peltola, M. T., Lilja, H. G., Nurmi, M. J., & Pettersson, K. S. I. (2006) · Analytical Chemistry · doi:10.1021/ac061201+ · Cited by 69
Self-citationUlmert, D., Becker, C., Nilsson, J., Piironen, T., Björk, T., Hugosson, J., Berglund, G. L., & Lilja, H. G. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.050641 · Cited by 66
Self-citationSteuber, T. P., Vickers, A. J., Serio, A. M., Väisänen, V., Haese, A., Pettersson, K. S. I., Eastham, J. A., Scardino, P. T., Huland, H., & Lilja, H. G. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.074963 · Cited by 62
Self-citationRe: Prostate Cancer Incidence and Mortality in the United States and the United Kingdom
Shibata, A., & Whittemore, A. S. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1109 · Cited by 40
Predictors of mortality after prostate-specific antigen failure
D'Amico, A. V., Kantoff, P. W., Loffredo, M. J., Renshaw, A. A., Loffredo, B., & Chen, M. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.053 · Cited by 37
Lundwall, Å., Clauss, A., & Olsson, A. Y. (2006) · Biological Chemistry · doi:10.1515/bc.2006.032 · Cited by 36
Lane, J. A., Howson, J., Donovan, J., Goepel, J. R., Dedman, D. J., Down, L., Turner, E. L., Neal, D. E., & Hamdy, F. C. (2007) · BMJ · doi:10.1136/bmj.39381.436829.be · Cited by 26
Roehl, K. A., Eggener, S. E., Loeb, S., Smith, N. D., Antenor, J. A. V., & Catàlona, W. J. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.11.039 · Cited by 22
Cited by
Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,090
Molecular genetics of prostate cancer: new prospects for old challenges
Shen, M. M., & Abate-Shen, C. (2010) · Genes & Development · doi:10.1101/gad.1965810 · Cited by 946
Protein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
Liquid biopsy in cancer: current status, challenges and future prospects
Ma, L., Guo, H., Zhao, Y., Liu, Z., Wang, C., Bu, J., Sun, T., & Wei, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02021-w · Cited by 712
Aptamer-Based Detection of Circulating Targets for Precision Medicine
Wu, L., Wang, Y., Xu, X., Liu, Y., Lin, B., Zhang, M., Zhang, J., Wan, S., Yang, C., & Tan, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01140 · Cited by 705
Metadata
- Authors
- Lilja, H., Ulmert, D., & Vickers, A. J.
- Venue
- Nature Reviews Cancer
- Published
- 2008-04
- Volume
- 8
- Issue
- 4
- Pages
- 268-278
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2002384741
- Cited by
- 921
- References
- 56
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.